NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/11/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization489.12 mln
Float10.82 mln
Earnings Date05/13/2026
EPS
0.35
Marginal
P / E
24.14
Premium valuation
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.28
Borderline
Relative Strength
69
/ 100
Outperforming
Debt / Equity
0.04
Debt-free
Business Description
Kamada Ltd. is an Israel-based biopharmaceutical company founded in 1990 that develops and produces therapeutic proteins derived from human plasma, with a focus on treating and preventing serious conditions such as rabies, hepatitis B, hemophilia, and inherited protein deficiencies. The company markets its own portfolio of specialty medicines globally while also acting as a distributor of third-party biopharmaceutical products within Israel, covering a broad range of conditions including respiratory disease, cancer, immunodeficiency, and rare genetic disorders.
